About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Houston | 162 Studies

Clinical Trials COPDHouston

COPD Clinical Trials in Houston

Find 162 clinical trials for copd near Houston, Texas. Connect with research centers in your area.

All COPD trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 162 trials

CompletedA Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)This study will assess the safety and efficacy of 5 doses GW642444 in subjects with Chonic Obstructive Pulmonary Disease (COPD)NCT00606684·Florence, Alabama and 98 others

PreviousPage 3 of 9Next

COPD Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Phase II, randomized, double-blind, placebo-controlled, parallel-group clinical trial of lebrikizumab in participants with COPD and a history of exacerbations who are treated with…NCT02546700·Birmingham, Alabama and 62 others

CompletedStudy To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate CombinationPH-797804 is an oral ant-inflammatory drug that may reduce the inflammation that is associated with COPD.NCT01321463·Mobile, Alabama and 73 others

CompletedA Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPDThis is a long-term safety trial of 48 weeks.NCT02276222·Andalusia, Alabama and 117 others

CompletedA Culturally Sensitive Values-Guided Aid for End of Life Decision-MakingThe goal of this research agenda is to improve the quality of end-of-life care by explicitly identifying values that will guide the decision-making process, with a particular…NCT00122135·Houston, Texas

CompletedSafety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)This study compared the safety and efficacy of indacaterol 150 µg taken once daily (o.d.) versus salmeterol 50 µg taken twice daily (b.i.d) in patients 40 years old or older with…NCT00821093·Anniston, Alabama and 143 others

TerminatedA 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.NCT04636814·Andalusia, Alabama and 459 others

Completed26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)Stage 1 of the study is designed to provide data about the risk-benefit of 4 dose regimens of indacaterol (75, 150, 300 \& 600 µg o.d.) in order to select two doses to carry…NCT00463567·Anniston, Alabama and 343 others

CompletedA 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus…NCT00784550·Riverside, California and 34 others

CompletedChronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyThis trial is a randomized, double-blind, parallel-group, multicenter study to be conducted in the United States.NCT01110200·Birmingham, Alabama and 102 others

CompletedCosts & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsAn analysis of the costs and outcomes associated with hospitalization and treatment of Levalbuterol versus Racemic Albuterol in subjects with Asthma and COPD.NCT00667797·Birmingham, Alabama and 17 others

CompletedDiagnosing Respiratory Disease in Children Using Cough SoundsThe purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in diagnosis of pneumonia and other respiratory conditions (bronchiolitis…NCT02973282·Boston, Massachusetts and 2 others

CompletedA Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThis is a randomized, double-blind, placebo-controlled, parallel arm study.NCT01706536·Jasper, Alabama and 25 others

RecruitingClinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningThe PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from…NCT06122077·Los Angeles, California and 35 others

Active not recruitingSymptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THSThe purpose of this randomized study is to demonstrate direct clinical benefit, i.e., observed benefits in how humans with COPD feel in terms of symptoms (e.g., cough frequency…NCT07108166·Clearwater, Florida and 111 others

CompletedEvaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.The Objectives of this study are to assess the safety of Aclidinium bromide on major adverse cardiovascular events (MACE), to assess the overall safety of Aclidinium bromide and…NCT01966107·Birmingham, Alabama and 467 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190209·Chandler, Arizona and 293 others

CompletedTiotropium / Respimat One-Year StudyTo evaluate the long term effects of treatment with two doses of Tiotropium delivered by the Respimat inhaler in patients with COPD.NCT00168844·Los Angeles, California and 71 others

UnknownClinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic BronchitisThis is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years.NCT04677465·Birmingham, Alabama and 36 others

CompletedStudy of the Effects of Education on Patients With Chronic Obstructive Pulmonary DiseaseThe investigators hypothesize that education will improve exercise capacity, symptoms and quality of life in patients with chronic obstructive pulmonary disease (COPD).NCT01633697·Houston, Texas and 1 other

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia